Literature DB >> 19479803

The utilization of liver transplantation in the management of acute liver failure: comparison between acetaminophen and non-acetaminophen etiologies.

Kenneth J Simpson1, Caroline M Bates, Neil C Henderson, Stephen J Wigmore, O James Garden, Alistair Lee, Antony Pollok, George Masterton, Peter C Hayes.   

Abstract

Liver transplantation (LT) may be life-saving in severe acute liver failure (ALF). The aim of this study was to compare the utilization of LT in acetaminophen and non-acetaminophen ALF. Between 1992 and 2006, 469 patients with ALF were admitted, and 104 underwent LT. Acetaminophen was the most common etiology, but LT proceeded more frequently in the non-acetaminophen cohort (acetaminophen: 45/326 patients received LT, 13.8%; non-acetaminophen: 59/143 patients received LT, 41.3%; P < 0.01). A retrospective analysis of the individual steps in the management of patients revealed more ALF patients in the non-acetaminophen cohort fulfilled the King's College Hospital poor prognostic criteria (non-acetaminophen: 91/143, 63.6%; acetaminophen: 165/326, 50.6%; P < 0.01), more patients had contraindications to LT in the acetaminophen cohort (acetaminophen: 99/165, 60%; non-acetaminophen: 21/91, 23.1%; P < 0.01), and survival on the LT waiting list was reduced in the acetaminophen cohort (acetaminophen: 45/66, 68.2%; non-acetaminophen: 59/70, 84.3%; P < 0.05). Post-LT survival was similar in the 2 groups. An analysis of cohorts admitted in 1993-1996 and 2002-2005 revealed that LT proceeded less commonly in acetaminophen ALF in the later cohort (1993-1996: 16/99 LT, 16.2%; 2002-2005: 4/81 LT, 5%; P < 0.01) in comparison with the non-acetaminophen cohort, in which transplantation proceeded more commonly in the later cohort (1993-1996: 11/34 LT, 32.4%; 2002-2005: 24/49 patients, 49.0%; P < 0.01). This was due to an increase in the number of patients with psychiatric contraindications to transplantation (predominantly resistant and severe alcohol dependence). In conclusion, at all decision steps between admission and emergency LT, LT is favored in non-acetaminophen patients, and nonoperative management is favored in acetaminophen ALF patients. (c) 2009 AASLD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19479803     DOI: 10.1002/lt.21681

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  27 in total

1.  Predicting daily outcomes in acetaminophen-induced acute liver failure patients with machine learning techniques.

Authors:  Jaime Lynn Speiser; Constantine J Karvellas; Bethany J Wolf; Dongjun Chung; David G Koch; Valerie L Durkalski
Journal:  Comput Methods Programs Biomed       Date:  2019-04-11       Impact factor: 5.428

2.  TRPM2 channels mediate acetaminophen-induced liver damage.

Authors:  Ehsan Kheradpezhouh; Linlin Ma; Arthur Morphett; Greg J Barritt; Grigori Y Rychkov
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

Review 3.  Acetaminophen (APAP) hepatotoxicity-Isn't it time for APAP to go away?

Authors:  William M Lee
Journal:  J Hepatol       Date:  2017-07-20       Impact factor: 25.083

4.  Understanding paracetamol-induced liver failure.

Authors:  Fin Stolze Larsen; Julia Wendon
Journal:  Intensive Care Med       Date:  2014-04-16       Impact factor: 17.440

5.  End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.

Authors:  Joseph Ahn; Taft Bhuket; Sasan Mosadeghi; Catherine Frenette; Benny Liu; Robert J Wong
Journal:  Hepatol Int       Date:  2016-05-24       Impact factor: 6.047

6.  On the Brink of Death: Managing Acute Liver Failure.

Authors:  Rahul Maheshwari; Ram M Subramanian
Journal:  Am J Gastroenterol       Date:  2016-12-13       Impact factor: 10.864

7.  Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity.

Authors:  Darren G N Craig; Caroline M Bates; Janice S Davidson; Kirsty G Martin; Peter C Hayes; Kenneth J Simpson
Journal:  Br J Clin Pharmacol       Date:  2012-02       Impact factor: 4.335

8.  Determinants of outcome among patients with acute liver failure listed for liver transplantation in the United States.

Authors:  K Rajender Reddy; Caitlyn Ellerbe; Michael Schilsky; R Todd Stravitz; Robert J Fontana; Valerie Durkalski; William M Lee
Journal:  Liver Transpl       Date:  2016-04       Impact factor: 5.799

9.  Overdose pattern and outcome in paracetamol-induced acute severe hepatotoxicity.

Authors:  Darren G N Craig; Caroline M Bates; Janice S Davidson; Kirsty G Martin; Peter C Hayes; Kenneth J Simpson
Journal:  Br J Clin Pharmacol       Date:  2011-02       Impact factor: 4.335

10.  Development of an accurate index for predicting outcomes of patients with acute liver failure.

Authors:  Anna Rutherford; Lindsay Y King; Linda S Hynan; Chetan Vedvyas; Wenyu Lin; William M Lee; Raymond T Chung
Journal:  Gastroenterology       Date:  2012-08-08       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.